Canada Drugs Direct

Visiting from Canada?

Want to save up to 80% on your medications? Signup below to be notified if we open a Canadian Online Pharmacy.

I agree to receive email updates from Canada Drugs Direct

Looking for CanadaDrugsDirect.net? Call us toll free 1-800-500-2897

Ubrelvy (Ubrogepant)

Prescription medicineOnly Available By Prescription
Sezzle

Top brand choice

Strength Pack Size Qty
Strength
50mg
Pack Size
Qty
Strength
100mg
Pack Size
Qty

You'll have option to make 4 interest-free payments by credit card once your order is confirmed using

What if I find a lower price with another pharmacy?

We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!

Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.

To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.

Terms & Conditions of Program

  • Guaranteed lowest price is only valid at the time of sale.
  • We will only match the current advertised price.
  • Products must be identical and in stock at the time of placing an order with a licensed mail order pharmacy. The must be a member of CIPA (Canadian International Pharmacy Association).
  • Products must be authentic in brand and size (same manufacturer, same country of manufacture, same pack size, same strength and same quantity).
  • Products must be new. We cannot match the price of any used, short expiry or expired product.
  • Price match can only be issued over the phone with our customer service team
What is a Generic Drug?

A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.

The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.

Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.

Description

Ubrelvy (Ubrogepant) is a medication used to treat acute migraine headaches in adults. It is a small-molecule antagonist of the calcitonin gene-related peptide (CGRP) receptor, which is involved in developing migraine headaches. Ubrelvy comes in tablet form and is taken by mouth.

By blocking the activity of CGRP, Ubrelvy helps to relieve the pain and other symptoms associated with migraines.


Fact Table

Formula

C29H26F3N5O3

License

US DailyMed

Bioavailability

40% Oral

Legal status

Rx-Only

Chemical Name

Ubrogepant

Elimination half-life

5 to 7 hours

Dosage (Strength)

100mg

Pregnancy

Consult Doctor

Brands

Ubrelvy

Protein binding

87%

PubChem CID

68748835

MedlinePlus

a620016

ChEBI

Not Available

ATC code

L01FA02

DrugBank

N02CD04

KEGG

D10673

Routes of administration

Oral

Directions

The recommended dosage is 50-100 mg, taken by mouth as needed.

The medication can be taken with or without food.

If the migraine headache returns after initial relief, a second dose may be taken at least two hours after the first dose. However, no more than 200 mg of Ubrelvy should be taken within a 24-hour period.

Ingredients

The active ingredient in Ubrelvy is ubrogepant.

Interactions

Common drug-drug interactions with this medication may include:

  • BCRP/ABCG2 Inhibitors
  • Ciprofloxacin
  • Clofazimine
  • CycloSPORINE
  • CYP3A4 Inducers
  • CYP3A4 Inhibitors
  • DeferasiroxErdafitinib
  • Fexinidazole
  • FluvoxaMINE
  • Fusidic Acid
  • Futibatinib
  • Gilteritinib
  • Interleukin-6 (IL-6) Inhibiting Therapies
  • Ivosidenib
  • Lasmiditan
  • Mavacamten
  • Olutasidenib
  • Pacritinib
  • P-glycoprotein/ABCB1 Inhibitors
  • Pitolisant
  • Pretomanid
  • Spironolactone
  • St John's Wort
  • Taurursodiol
  • Treosulfan
  • Voxilaprevir

Cautions

Individuals with a history of stroke, heart attack, or other cardiovascular diseases should not use Ubrelvy.

It also should not be used by individuals with uncontrolled high blood pressure or severe liver impairment.

Women who are pregnant or breastfeeding should talk to their doctor before taking Ubrelvy.

Tell your doctor if you have a history of kidney or liver problems before starting Ubrelby because the dosage might need to be adjusted.

Tell your doctor if you are taking drugs that prolong the QT interval, such as amiodarone, quinidine, and sotalol. This combination may increase the risk of heart rhythm problems when taken with Ubrelvy.

Side Effects

The most common side effects may include the following:

  • Drowsiness
  • Nausea
  • Xerostomia

References

  1. Ubrelvy [package insert]. Madison, NJ: Allergan USA, Inc; 2019.

IMPORTANT NOTE: The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.

product-reviews Product Reviews